Funding: The study is funded by The Barts Charity, grant ECMG1B6R. Acknowledgments: D.G.E. is supported by the Manchester NIHR Biomedical Research Centre (IS- BRC-1215-20007). OB thanks the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Center „Digital biodesign and personalized healthcare” 075-15-2020-926.Peer reviewedPublisher PDFsupplementary_dat
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibi...
The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs...
Universal tumor DNA testing in epithelial ovarian cancer patients can function not only as an effici...
We present findings of a cancer multidisciplinary-team (MDT) coordinated mainstreaming pathway of un...
We present findings of a cancer multidisciplinary-team (MDT) coordinated mainstreaming pathway of un...
Genetic testing for germline-BRCA1/BRCA2 mutations in epithelial ovarian cancer (EOC) was commission...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
To access publisher's full text version of this article click on the hyperlink belowLarge-scale geno...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
An assay for the single nucleotide polymorphism (SNP) rs61764370 has recently been commercially mark...
Objective To determine the frequency of germline and somatic pathogenic BRCA1 and BRCA2 variants in...
Purpose: Next-generation sequencing (NGS) allows simultaneous sequencing of multiple cancer suscepti...
SummaryWe conducted a population-based study to determine the contribution of germline mutations in ...
OBJECTIVE: Ovarian cancer is a hormone-related disease with a strong genetic basis. However, none of...
Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in ...
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibi...
The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs...
Universal tumor DNA testing in epithelial ovarian cancer patients can function not only as an effici...
We present findings of a cancer multidisciplinary-team (MDT) coordinated mainstreaming pathway of un...
We present findings of a cancer multidisciplinary-team (MDT) coordinated mainstreaming pathway of un...
Genetic testing for germline-BRCA1/BRCA2 mutations in epithelial ovarian cancer (EOC) was commission...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
To access publisher's full text version of this article click on the hyperlink belowLarge-scale geno...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
An assay for the single nucleotide polymorphism (SNP) rs61764370 has recently been commercially mark...
Objective To determine the frequency of germline and somatic pathogenic BRCA1 and BRCA2 variants in...
Purpose: Next-generation sequencing (NGS) allows simultaneous sequencing of multiple cancer suscepti...
SummaryWe conducted a population-based study to determine the contribution of germline mutations in ...
OBJECTIVE: Ovarian cancer is a hormone-related disease with a strong genetic basis. However, none of...
Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in ...
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibi...
The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs...
Universal tumor DNA testing in epithelial ovarian cancer patients can function not only as an effici...